Received Jul 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 99D52 | LA |
swollen lymph nodes at the location of her left collar bone and left upper arm; felt pain after the injection.; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult female patient who received Herpes zoster (Shingrix) (batch number 99D52, expiry date 25-MAR-2027) for prophylaxis. Previously administered products included Shingrix (received 1st dose of vaccine on an unknown date). On 29-JUN-2025, the patient received the 2nd dose of Shingrix (left arm) .5 ml. On 29-JUN-2025, immediately after receiving Shingrix, the patient experienced pain in arm (Verbatim: felt pain after the injection.). On 01-JUL-2025, the patient experienced swollen lymph nodes (Verbatim: swollen lymph nodes at the location of her left collar bone and left upper arm). The outcome of the pain in arm was resolving and the outcome of the swollen lymph nodes was not resolved. It was unknown if the reporter considered the pain in arm and swollen lymph nodes to be related to Shingrix. It was unknown if the company considered the pain in arm and swollen lymph nodes to be related to Shingrix. Additional Information: GSK Receipt Date: 02-JUL-2025 The reporter was the patient who received her 2nd dose of Shingrix on the 29th of June 2025 in her left arm. The reporter stated that she immediately felt pain after the injection. The pain was still ongoing, but it was not as severe as it was before. The reporter stated that yesterday the 1st of July 2025 she noticed swollen lymph nodes at the location of her left collar bone and left upper arm. The reporter did not want to give her date of birth and states she was an adult over the age of 50 years old.